Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

HA-15 is an inhibitor of glucose-regulated protein 78 kDa (GRP78), also known as heat shock 70 kDa protein 5 (HspA5) and immunoglobulin heavy chain-binding protein (BiP), a cellular chaperone.1 It binds to GRP79 in a cell-free assay and increases the expression of the genes encoding the unfolded protein response (UPR) proteins EIF2AK3, IRE1α, ATF6, DDIT3, and XBP1, as well as the apoptosis-associated genes JUN and BCL2 and the autophagy marker gene LC3. HA-15 decreases the viability of A375 melanoma cells (IC50 = 2.5 µM). In vivo, HA-15 (0.7 mg/animal per day) reduces tumor volume and induces intratumor apoptosis and autophagy in an A375 mouse xenograft model. HA-15 also increases osteogenesis and reduces bone loss in a mouse model of ovariectomy-induced osteoporosis.2
WARNING This product is not for human or veterinary use.
1. Compounds triggering ER stress exert anti-
2. HA15 alleviates bone loss in ovariectomy-